Vasopressin and its antagonists: what are their roles in acute medical care?

can predict cardiac failure after cardiac surgery. Circ J 2007; 71: 79–83 20 Kerbaul F, Giorgi R, Oddoze C, et al. High concentrations of N-BNP are related to non-infectious severe SIRS associated with cardiovascular dysfunction occurring after off-pump coronary artery surgery. Br J Anaesth 2004; 93: 639–44 21 Guerin V, Ayed SB, Varnous S, et al. Release of brain natriuretic-related peptides (BNP, NT-proBNP) and cardiac troponins (cTnT, cTnI) in on-pump and off-pump coronary artery bypass surgery. Surg Today 2006; 36: 783–9 22 Gardner RS, Chong KS, Murday AJ, Morton JJ, McDonagh TA. N-terminal brain natriuretic peptide is predictive of death after cardiac transplantation. Heart 2006; 92: 121–3 23 Berendes E, Van Aken H, Raufhake C, et al. Differential secretion of atrial and brain natriuretic peptide in critically ill patients. Anesth Analg 2001; 93: 676–825 24 Brueckmann M, Huhle G, Lang S, et al. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation 2005; 112: 527–34 25 Almog Y, Novack V, Megralishvili R, et al. Plasma level of N terminal pro-brain natriuretic peptide as a prognostic marker in critically ill patients. Anesth Analg 2006; 102: 1809–15 26 Cuthbertson BH, Patel RR, Croal BL, Barclay J, Hillis GS. B-type natriuretic peptide and the prediction of outcome in patients admitted to intensive care. Anaesthesia 2005; 60: 16–21 27 Manikandan R, Nathaniel C, Lewis P, et al. Troponin T and N-terminal pro-brain natriuretic peptide changes in patients undergoing transurethral resection of prostate. J Urol 2005; 174: 1892–5 28 Yeh HM, Lau HP, Lin JM, et al. Preoperative plasma N-terminal pro-brain natriuretic peptide as a marker of cardiac risk in patients undergoing elective non-cardiac surgery. Br J Surg 2005; 92: 1041–5 29 Feringa HH, Bax JJ, Elhendy A, et al. Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass. Am J Cardiol 2006; 98: 111–5 30 Dernellis J, Panaretou M. Assessment of cardiac risk before noncardiac surgery: brain natriuretic peptide in 1590 patients. Heart 2006; 92: 1645–50 31 Gibson SC, Payne CJ, Byrne DS, et al. B-type natriuretic peptide predicts cardiac morbidity and mortality after major surgery. Br J Surg 2007; 94: 903–9 32 Cuthbertson BH, Amiri AR, Croal BL, et al. The utility of B-type natriuretic peptide in predicting perioperative cardiac events in patients undergoing major non-cardiac surgery. Br J Anaesth 2007; 99: 170–6 33 Mahla E, Baumann A, Rehak P, et al. N-terminal pro-brain natriuretic peptide identifies patients at high risk for adverse cardiac outcome after vascular surgery. Anesthesiology 2007; 106: 1088–95